Vitamin D deficiency: Implications for acute care in the elderly and in patients with chronic illness

Geriatrics and Gerontology International

Volumn 11, Issue 4, 2011, Pages 395-407

  Youssef, Dima A ^a,b   El Abbassi, Adel M ^a,b   Cutchins, Della C ^a   Chhabra, Shalini ^a   Peiris, Alan N ^a,b  

^a Mountain Home VAMC Medicine Service   (United States)

^b East Tennessee State University   (United States)

Author keywords

Acute illness; Chronic illness; Deficiency; Elderly; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; COLECALCIFEROL; ERGOCALCIFEROL; PLACEBO; STEROID HORMONE; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

ANTIMICROBIAL ACTIVITY; AUTOCRINE EFFECT; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CHRONIC KIDNEY DISEASE; COGNITIVE DEFECT; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MEGADOSE; ELDERLY CARE; EMERGENCY CARE; GLUCOSE METABOLISM; HIGH RISK POPULATION; HUMAN; IMMUNOMODULATION; INFECTION; LENGTH OF STAY; LIPID METABOLISM; LONGEVITY; LUNG TUBERCULOSIS; MORTALITY; PAIN; PARACRINE SIGNALING; PRIORITY JOURNAL; REVIEW; SUNLIGHT; TUBERCULOSIS; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; HUMANS; PREVALENCE; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 80053222288     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/j.1447-0594.2011.00716.x     Document Type: Review

References (153)

1. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281.
2. Egan KM, Signorello LB, Munro HM, Hargreaves MK, Hollis BW, Blot WJ. Vitamin D insufficiency among African-Americans in the southeastern United States: implications for cancer disparities (United States). Cancer Causes Control 2008; 19: 527-535.
3. Grant WB. Epidemiology of disease risks in relation to vitamin D insufficiency. Prog Biophys Mol Biol 2006; 92: 65-79.
4. Bikle DD. Vitamin D: newly discovered actions require reconsideration of physiologic requirements. Trends Endocrinol Metab 2010; 21: 375-384.
5. Ginde AA, Liu MC, Camargo CAJ. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009; 169: 626-632.
6. Peiris AN, Bailey B, Manning T, Kuriacose R, Copeland R, Garrett L. Testing for vitamin D deficiency in veterans-is there a seasonal bias? J Am Med Dir Assoc 2010; 11: 128-131.
7. Cashman KD, Wallace JM, Horigan G etal. Estimation of the dietary requirement for vitamin D in free-living adults >=64y of age. Am J Clin Nutr 2009; 89: 1366-1374.
8. Peiris AN, Bailey BA, Manning T. The relationship of vitamin D deficiency to health care costs in veterans. Mil Med 2008; 173: 1214-1218.
9. Grant WB, Cross HS, Garland CF etal. Estimated benefit of increased vitamin D status in reducing the economic burden of disease in western Europe. Prog Biophys Mol Biol 2009; 99: 104-113.
10. Newens K, Filteau S, Tomkins A. Plasma 25-hydroxyvitamin D does not vary over the course of a malarial infection. Trans R Soc Trop Med Hyg 2006; 100: 41-44.
11. Krishnan A, Ochola J, Jet M. al.Acute fluid shifts influence the assessment of serum vitamin D status in critically ill patients. Crit Care 2010; 14: R216.
12. Nemunaitis GA, Mejia M, Nagy JA, Johnson T, Chae J, Roach MJ. A descriptive study on vitamin D levels in individuals with spinal cord injury in an acute inpatient rehabilitation setting. PM R 2010; 2: 202-208; quiz 228.
13. Lee P, Nair P, Eisman JA, Center JR. Vitamin D deficiency in the intensive care unit: an invisible accomplice to morbidity and mortality? Intensive Care Med 2009; 35: 2028-2032.
14. McKinney JD, Bailey BA, Garrett LH, Peiris P, Manning T, Peiris AN. Relationship between Vitamin D status and ICU outcomes in Veterans. J Am Med Dir Assoc 2011; 12: 208-211.
15. Mata-Granados JM, Vargas-Vasserot J, Ferreiro-Vera C, Luque de Castro MD, Pavon RG, Quesada Gomez JM. Evaluation of vitamin D endocrine system (VDES) status and response to treatment of patients in intensive care units (ICUs) using an on-line SPE-LC-MS/MS method. J Steroid Biochem Mol Biol 2010; 121: 452-455.
16. Andersson I, Gronberg A, Slinde F, Bosaeus I, Larsson S. Vitamin and mineral status in elderly patients with chronic obstructive pulmonary disease. Clin Respir J 2007; 1: 23-29.
17. Thomas MK, Lloyd-Jones DM, Thadhani RI etal. Hypovitaminosis D in medical inpatients. N Engl J Med 1998; 338: 777-783.
18. Lee P, Samaras K, Glanville AR, Center JR. Transplant recipients on the edge of the hypocalcemia abyss. J Heart Lung Transplant 2009; 28: 93-95.
19. Van den Berghe G, Van Roosbroeck D, Vanhove P, Wouters PJ, De Pourcq L, Bouillon R. Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab 2003; 88: 4623-4632.
20. Shimoni Z, Niven M, Kama N, Dusseldorp N, Froom P. Increased complaints of fever in the emergency room can identify influenza epidemics. Eur J Intern Med 2008; 19: 494-498.
21. Cannell JJ, Vieth R, Umhau JC etal. Epidemic influenza and vitamin D. Epidemiol Infect 2006; 134: 1129-1140.
22. Kamen DL, Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med 2010; 88: 441-450.
23. Gombart AF. The vitamin d-antimicrobial peptide pathway and its role in protection against infection. Future Microbiol 2009; 4: 1151-1165.
24. Shapira Y, Agmon-Levin N, Shoenfeld Y. Mycobacterium tuberculosis, autoimmunity, and vitamin D. Clin Rev Allergy Immunol 2010; 38: 169-177.
25. Bartley J. Vitamin D, innate immunity and upper respiratory tract infection. J Laryngol Otol 2010; 124: 465-469.
26. De la Torre MS, Torres C, Nieto G etal. Vitamin D receptor gene haplotypes and susceptibility to HIV-1 infection in injection drug users. J Infect Dis 2008; 197: 405-410.
27. Conrado T, Miranda-Filho Dde B, Bandeira F. Vitamin D deficiency in HIV-infected individuals: one more risk factor for bone loss and cardiovascular disease? Arq Bras Endocrinol Metabol 2010; 54: 118-122.
28. Bitetto D, Fabris C, Fornasiere E etal. Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C. Transpl Int 2011; 24: 43-50.
29. Beigel JH, Farrar J, Han AM etal. Avian influenza A (H5N1) infection in humans. N Engl J Med 2005; 353: 1374-1385.
30. Chan MC, Cheung CY, Chui WH etal. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 2005; 6: 135.
31. Sabetta JR, DePetrillo P, Cipriani RJ, Smardin J, Burns LA, Landry ML. Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults. PLoS One 2010; 5: e11088.
32. Banerjee A, Damera G, Bhandare R etal. Vitamin D and glucocorticoids differentially modulate chemokine expression in human airway smooth muscle cells. Br J Pharmacol 2008; 155: 84-92.
33. Sutherland ER, Goleva E, Jackson LP, Stevens AD, Leung DY. Vitamin D levels, lung function, and steroid response in adult asthma. Am J Respir Crit Care Med 2010; 181: 699-704.
34. Grant WB, Garland CF. The role of vitamin D3 in preventing infections. Age Ageing 2008; 37: 121-122.
35. Ginde AA, Mansbach JM, Camargo CAJ. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 2009; 169: 384-390.
36. Edlich RF, Mason SS, Dahlstrom JJ, Swainston E, Long WB, Gubler K. Pandemic preparedness for swine flu influenza in the United States. J Environ Pathol Toxicol Oncol 2009; 28: 261-264.
37. Yamamoto N, Urade M. Pathogenic significance of alpha-N-acetylgalactosaminidase activity found in the hemagglutinin of influenza virus. Microbes Infect 2005; 7: 674-681.
38. Youssef D, Bailey B, El Abbassi A etal. Healthcare costs of Staphylococcus aureus and Clostridium difficile infections in Veterans: role of vitamin D deficiency. Epidemiol Infect 2010; 138: 1322-1327.
39. Selvaraj P, Alagarasu K, Harishankar M, Vidyarani M, Narayanan PR. Regulatory region polymorphisms of vitamin D receptor gene in pulmonary tuberculosis patients and normal healthy subjects of south India. Int J Immunogenet 2008; 35: 251-254.
40. Douglas AS, Strachan DP, Maxwell JD. Seasonality of tuberculosis: the reverse of other respiratory diseases in the UK. Thorax 1996; 51: 944-946.
41. Martineau AR, Timms PM, Bothamley GH etal. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 2011; 377: 242-250.
42. Nursyam EW, Amin Z, Rumende CM. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones 2006; 38: 3-5.
43. Zaloga GP, Chernow B. The multifactorial basis for hypocalcemia during sepsis. Studies of the parathyroid hormone-vitamin D axis. Ann Intern Med 1987; 107: 36-41.
44. Moller S, Laigaard F, Olgaard K, Hemmingsen C. Effect of 1, 25-dihydroxy-vitamin D3 in experimental sepsis. Int J Med Sci 2007; 4: 190-195.
45. Huff GR, Huff WE, Balog JM, Rath NC. The effect of vitamin D3 on resistance to stress-related infection in an experimental model of turkey osteomyelitis complex. Poult Sci 2000; 79: 672-679.
46. Silva ME, Silva ME, Silva ME, Nicoli JR, Bambirra EA, Vieira EC. Vitamin D overload and experimental Trypanosoma cruzi infection: parasitological and histopathological aspects. Comp Biochem Physiol Comp Physiol 1993; 104: 175-181.
47. Kitajima I, Maruyama I, Matsubara H, Osame M, Igata A. Immune dysfunction in hypophosphatemic vitamin d-resistant rickets: immunoregulatory reaction of 1 alpha(OH) vitamin D3. Clin Immunol Immunopathol 1989; 53: 24-31.
48. Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr Opin Pharmacol 2010; 10: 482-496.
49. Jeng L, Yamshchikov AV, Judd SE etal. Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med 2009; 7: 28.
50. Hiemstra PS. The role of epithelial beta-defensins and cathelicidins in host defense of the lung. Exp Lung Res 2007; 33: 537-542.
51. Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1, 25-dihydroxyvitamin D3. FASEB J 2005; 19: 1067-1077.
52. Liu PT, Stenger S, Tang DH, Modlin RL. Cutting edge: vitamin d-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol 2007; 179: 2060-2063.
53. Liu PT, Stenger S, Li H etal. Toll-like receptor triggering of a vitamin d-mediated human antimicrobial response. Science 2006; 311: 1770-1773.
54. Hansdottir S, Monick MM, Lovan N, Powers L, Gerke A, Hunninghake GW. Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state. J Immunol 2010; 184: 965-974.
55. Plitas G, Burt BM, Nguyen HM, Bamboat ZM, DeMatteo RP. Toll-like receptor 9 inhibition reduces mortality in polymicrobial sepsis. J Exp Med 2008; 205: 1277-1283.
56. Barnett AG, de Looper M, Fraser JF. The seasonality in heart failure deaths and total cardiovascular deaths. Aust N Z J Public Health 2008; 32: 408-413.
57. Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2006; 83: 754-759.
58. Scragg RK, Camargo CAJ, Simpson RU. Relation of serum 25-hydroxyvitamin D to heart rate and cardiac work (from the National Health and Nutrition Examination Surveys). Am J Cardiol 2010; 105: 122-128.
59. Kim DH, Sabour S, Sagar UN, Adams S, Whellan DJ. Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am J Cardiol 2008; 102: 1540-1544.
60. Zia AA, Komolafe BO, Moten M etal. Supplemental vitamin D and calcium in the management of African Americans with heart failure having hypovitaminosis D. Am J Med Sci 2011; 341: 113-118.
61. Timms PM, Mannan N, Hitman GA etal. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM 2002; 95: 787-796.
62. Parker J, Hashmi O, Dutton D etal. Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas 2010; 65: 225-236.
63. Pittas AG, Chung M, Trikalinos T etal. Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med 2010; 152: 307-314.
64. Kilkkinen A, Knekt P, Aro A etal. Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol 2009; 170: 1032-1039.
65. Baz-Hecht M, Goldfine AB. The impact of vitamin D deficiency on diabetes and cardiovascular risk. Curr Opin Endocrinol Diabetes Obes 2010; 17: 113-119.
66. Ogawa T, Ishida H, Akamatsu M etal. Relation of oral 1alpha-hydroxy vitamin D3 to the progression of aortic arch calcification in hemodialysis patients. Heart Vessels 2010; 25: 1-6.
67. Freedman BI, Wagenknecht LE, Hairston KG etal. Vitamin d, adiposity, and calcified atherosclerotic plaque in african-americans. J Clin Endocrinol Metab 2010; 95: 1076-1083.
68. de Francisco AL. Secondary hyperparathyroidism: review of the disease and its treatment. Clin Ther 2004; 26: 1976-1993.
69. Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr 1956; 4: 20-34.
70. Davis W, Rockway S, Kwasny M. Effect of a combined therapeutic approach of intensive lipid management, omega-3 fatty acid supplementation, and increased serum 25 (OH) vitamin D on coronary calcium scores in asymptomatic adults. Am J Ther 2009; 16: 326-332.
71. Gaddipati VC, Kuriacose R, Copeland R, Bailey BA, Peiris AN. Vitamin D deficiency: an increasing concern in peripheral arterial disease. J Am Med Dir Assoc 2010; 11: 308-311.
72. Reis JP, Michos ED, von Mühlen D, Miller ER 3rd. Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease. Am J Clin Nutr 2008; 88: 1469-1477.
73. Agarwal R. Are vitamin D receptor agonists like angiotensin-converting enzyme inhibitors without side effects? Kidney Int 2010; 77: 943-945.
74. Grimes DS. Are statins analogues of vitamin D? Lancet 2006; 368: 83-86.
75. Bell DS. Resolution of statin-induced myalgias by correcting vitamin D deficiency. South Med J 2010; 103: 690-692.
76. Perez-Castrillon JL, Vega G, Abad L etal. Effects of Atorvastatin on vitamin D levels in patients with acute ischemic heart disease. Am J Cardiol 2007; 99: 903-905.
77. Jean G, Lataillade D, Genet L etal. Impact of hypovitaminosis D and alfacalcidol therapy on survival of hemodialysis patients: results from the French ARNOS study. Nephron Clin Pract 2010; 118: c204-c210.
78. Grant WB, Peiris AN. Possible role of serum 25-hydroxyvitamin D in black-white health disparities in the United States. J Am Med Dir Assoc 2010; 11: 617-628.
79. Wolf M, Betancourt J, Chang Y etal. Impact of activated vitamin D and race on survival among hemodialysis patients. J Am Soc Nephrol 2008; 19: 1379-1388.
80. Choi HS, Kim SH, Rhee Y, Cho MA, Lee EJ, Lim SK. Serum parathyroid hormone is associated with carotid intima-media thickness in postmenopausal women. Int J Clin Pract 2008; 62: 1352-1357.
81. Gilardini L, Pasqualinotto L, Di Matteo S etal. Factors Associated With Early Atherosclerosis and Arterial Calcifications in Young Subjects With a Benign Phenotype of Obesity. Obesity (Silver Spring). 2011. doi:10.1038/oby.2010.342
82. Slatopolsky E, Brown A, Dusso A. Role of phosphorus in the pathogenesis of secondary hyperparathyroidism. Am J Kidney Dis 2001; 37: S54-S57.
83. Verstuyf A, Carmeliet G, Bouillon R, Mathieu C. Vitamin D: a pleiotropic hormone. Kidney Int 2010; 78: 140-145.
84. Lips P. Vitamin D physiology. Prog Biophys Mol Biol 2006; 92: 4-8.
85. Patel TV, Singh AK. Role of vitamin D in chronic kidney disease. Semin Nephrol 2009; 29: 113-121.
86. Wolf M. Fibroblast growth factor 23 and the future of phosphorus management. Curr Opin Nephrol Hypertens 2009; 18: 463-468.
87. Patel NM, Gutiérrez OM, Andress DL, Coyne DW, Levin A, Wolf M. Vitamin D deficiency and anemia in early chronic kidney disease. Kidney Int 2010; 77: 715-720.
88. Jones G. Expanding role for vitamin D in chronic kidney disease: importance of blood 25-OH-D levels and extra-renal 1alpha-hydroxylase in the classical and nonclassical actions of 1alpha, 25-dihydroxyvitamin D(3). Semin Dial 2007; 20: 316-324.
89. Roesel TR. Vitamin D deficiency in Iraq and Afghanistan veterans with chronic musculoskeletal pain. J Occup Environ Med 2008; 50: 613-614.
90. Helliwell PS, Ibrahim GH, Karim Z, Sokoll K, Johnson H. Unexplained musculoskeletal pain in people of South Asian ethnic group referred to a rheumatology clinic - relationship to biochemical osteomalacia, persistence over time and response to treatment with calcium and vitamin D. Clin Exp Rheumatol 2006; 24: 424-427.
91. Van Veldhuizen PJ, Taylor SA, Williamson S, Drees BM. Treatment of vitamin D deficiency in patients with metastatic prostate cancer may improve bone pain and muscle strength. J Urol 2000; 163: 187-190.
92. Bazzani C, Arletti R, Bertolini A. Pain threshold and morphine activity in vitamin d-deficient rats. Life Sci 1984; 34: 461-466.
93. Staud R. Vitamin D: more than just affecting calcium and bone. Curr Rheumatol Rep 2005; 7: 356-364.
94. Bergman GJ, Fan T, McFetridge JT, Sen SS. Efficacy of vitamin D3 supplementation in preventing fractures in elderly women: a meta-analysis. Curr Med Res Opin 2010; 26: 1193-1201.
95. Bischoff HA, Stahelin HB, Dick W etal. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 2003; 18: 343-351.
96. Jackson RD, LaCroix AZ, Gass M etal. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006; 354: 669-683.
97. Grant AM, Avenell A, Campbell MK etal. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 2005; 365: 1621-1628.
98. Holick MF, Siris ES, Binkley N etal. Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005; 90: 3215-3224.
99. Sanders KM, Stuart AL, Williamson EJ etal. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 2010; 303: 1815-1822.
100. Moreira-Pfrimer LD, Pedrosa MA, Teixeira L, Lazaretti-Castro M. Treatment of vitamin D deficiency increases lower limb muscle strength in institutionalized older people independently of regular physical activity: a randomized double-blind controlled trial. Ann Nutr Metab 2009; 54: 291-300.
101. Youssef D, El Abbassi A, Jones K, Woodby G, Peiris AN. The potential to improve diabetes control with vitamin D replacement in African American patients: case report and literature review. Tenn Med 2010; 103: 35-36.
102. Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001; 358: 1500-1503.
103. Joergensen C, Gall MA, Schmedes A, Tarnow L, Parving HH, Rossing P. Vitamin D levels and mortality in type 2 diabetes. Diabetes Care 2010; 33: 2238-2243.
104. von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial. Br J Nutr 2010; 103: 549-555.
105. Alvarez JA, Bush NC, Choquette SS etal. Vitamin D intake is associated with insulin sensitivity in African American, but not European American, women. Nutr Metab (Lond) 2010; 7: 28.
106. Calle C, Maestro B, Garcia-Arencibia M. Genomic actions of 1, 25-dihydroxyvitamin D3 on insulin receptor gene expression, insulin receptor number and insulin activity in the kidney, liver and adipose tissue of streptozotocin-induced diabetic rats. BMC Mol Biol 2008; 9: 65.
107. Rejnmark L, Vestergaard P, Heickendorff L, Mosekilde L. Simvastatin does not affect vitamin d status, but low vitamin d levels are associated with dyslipidemia: results from a randomised, controlled trial. Int J Endocrinol 2010; 2010: 957174.
108. Riek AE, Oh J, Bernal-Mizrachi C. Vitamin D regulates macrophage cholesterol metabolism in diabetes. J Steroid Biochem Mol Biol 2010; 121: 430-433.
109. Liel Y, Ulmer E, Shary J, Hollis BW, Bell NH. Low circulating vitamin D in obesity. Calcif Tissue Int 1988; 43: 199-201.
110. Lee P, Campbell LV. Vitamin D deficiency: the invisible accomplice of metabolic endotoxemia? Curr Pharm Des 2009; 15: 2751-2758.
111. Delvin EE, Lambert M, Levy E etal. Vitamin D status is modestly associated with glycemia and indicators of lipid metabolism in French-Canadian children and adolescents. J Nutr 2010; 140: 987-991.
112. Przybelski RJ, Binkley NC. Is vitamin D important for preserving cognition? A positive correlation of serum 25-hydroxyvitamin D concentration with cognitive function. Arch Biochem Biophys 2007; 460: 202-205.
113. Barnard K, Colon-Emeric C. Extraskeletal effects of vitamin D in older adults: cardiovascular disease, mortality, mood, and cognition. Am J Geriatr Pharmacother 2010; 8: 4-33.
114. Magrassi L, Bono F, Milanesi G, Butti G. Vitamin D receptor expression in human brain tumors. J Neurosurg Sci 1992; 36: 27-30.
115. Trouillas P, Honnorat J, Bret P, Jouvet A, Gerard JP. Redifferentiation therapy in brain tumors: long-lasting complete regression of glioblastomas and an anaplastic astrocytoma under long term 1-alpha-hydroxycholecalciferol. J Neurooncol 2001; 51: 57-66.
116. Cekic M, Stein DG. Traumatic brain injury and aging: is a combination of progesterone and vitamin D hormone a simple solution to a complex problem? Neurotherapeutics 2010; 7: 81-90.
117. Atif F, Sayeed I, Ishrat T, Stein DG. Progesterone with vitamin D affords better neuroprotection against excitotoxicity in cultured cortical neurons than progesterone alone. Mol Med 2009; 15: 328-336.
118. Humble MB, Gustafsson S, Bejerot S. Low serum levels of 25-hydroxyvitamin D (25-OHD) among psychiatric out-patients in Sweden: relations with season, age, ethnic origin and psychiatric diagnosis. J Steroid Biochem Mol Biol 2010; 121: 467-470.
119. Mikati M, Wakim RH, Fayad M. Symptomatic antiepileptic drug associated vitamin D deficiency in noninstitutionalized patients: an under-diagnosed disorder. J Med Liban 2003; 51: 71-73.
120. Sim JJ, Lac PT, Liu IL etal. Vitamin D deficiency and anemia: a cross-sectional study. Ann Hematol 2010; 89: 447-452.
121. Cannell JJ, Hollis BW. Use of vitamin D in clinical practice. Altern Med Rev 2008; 13: 6-20.
122. Vieth R. How to optimize vitamin D supplementation to prevent cancer, based on cellular adaptation and hydroxylase enzymology. Anticancer Res 2009; 29: 3675-3684.
123. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999; 69: 842-856.
124. Cannell JJ, Hollis BW, Zasloff M, Heaney RP. Diagnosis and treatment of vitamin D deficiency. Expert Opin Pharmacother 2008; 9: 107-118.
125. Aloia JF, Talwar SA, Pollack S, Yeh J. A randomized controlled trial of vitamin D3 supplementation in African American women. Arch Intern Med 2005; 165: 1618-1623.
126. Barger-Lux MJ, Heaney RP. Effects of above average summer sun exposure on serum 25-hydroxyvitamin D and calcium absorption. J Clin Endocrinol Metab 2002; 87: 4952-4956.
127. Peiris AN, Bailey BA, Manning T, Adebonojo L. Are 25-hydroxyvitamin D levels adequately monitored following evidence of vitamin D insufficiency in veterans? Mil Med 2010; 175: 453-456.
128. Pepper KJ, Judd SE, Nanes MS, Tangpricha V. Evaluation of vitamin D repletion regimens to correct vitamin D status in adults. Endocr Pract 2009; 15: 95-103.
129. Burton JM, Kimball S, Vieth R etal. A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology 2010; 74: 1852-1859.
130. Von Restorff C, Bischoff-Ferrari HA, Theiler R. High-dose oral vitamin D3 supplementation in rheumatology patients with severe vitamin D3 deficiency. Bone 2009; 45: 747-749.
131. Einarsdottir K, Preen DB, Clay TD, Kiely L, Holman CD, Cohen LD. Effect of a single 'megadose' intramuscular vitamin D (600, 000IU) injection on vitamin D concentrations and bone mineral density following biliopancreatic diversion surgery. Obes Surg 2010; 20: 732-737.
132. Nugent C, Roche K, Wilson S etal. The effect of intramuscular vitamin D (cholecalciferol) on serum 25OH vitamin D levels in older female acute hospital admissions. Ir J Med Sci 2010; 179: 57-61.
133. Bordier P, Hioco D, Rouquier M, Hepner GW, Thompson GR. Effects of intravenous vitamin D on bone and phosphate metabolism in osteomalacia. Calcif Tissue Res 1969; 4: 78-83.
134. Lyman D. Undiagnosed vitamin D deficiency in the hospitalized patient. Am Fam Physician 2005; 71: 299-304.
135. St Peter WL, Li S, Liu J, Gilbertson DT, Arneson TJ, Collins AJ. Effects of monthly dose and regular dosing of intravenous active vitamin D use on mortality among patients undergoing hemodialysis. Pharmacotherapy 2009; 29: 154-164.
136. Armas LA, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 2004; 89: 5387-5391.
137. Leventis P, Kiely PD. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency. Scand J Rheumatol 2009; 38: 149-153.
138. Romagnoli E, Mascia ML, Cipriani C etal. Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J Clin Endocrinol Metab 2008; 93: 3015-3020.
139. Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 2007; 167: 1730-1737.
140. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007; 85: 1586-1591.
141. Lefebvre d'Hellencourt C, Montero-Menei CN, Bernard R, Couez D. Vitamin D3 inhibits proinflammatory cytokines and nitric oxide production by the EOC13 microglial cell line. J Neurosci Res 2003; 71: 575-582.
142. Riancho JA, Zarrabeitia MT, de Francisco AL etal. Vitamin D therapy modulates cytokine secretion in patients with renal failure. Nephron 1993; 65: 364-368.
143. Grant WB, Schwalfenberg GK, Genuis SJ, Whiting SJ. An estimate of the economic burden and premature deaths due to vitamin D deficiency in Canada. Mol Nutr Food Res 2010; 54: 1172-1181.
144. Carlton S, Clopton D, Cappuzzo KA. Vitamin D deficiency: appropriate replenishment therapies and the effects of vitamin D toxicity. Consult Pharm 2010; 25: 171-177.
145. Stephenson DW, Peiris AN. The lack of vitamin D toxicity with megadose of daily ergocalciferol (D2) therapy: a case report and literature review. South Med J 2009; 102: 765-768.
146. Jones G. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr 2008; 88: 582S-586S.
147. Lee DC, Lee GY. The use of pamidronate for hypercalcemia secondary to acute vitamin D intoxication. J Toxicol Clin Toxicol 1998; 36: 719-721.
148. Gurkan F, Davutoglu M, Bosnak M etal. Pamidronate treatment in acute vitamin D intoxication. J Endocrinol Invest 2004; 27: 680-682.
149. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006; 84: 18-28.
150. Ross AC, Manson JE, Abrams SA etal. The 2011 report on dietary reference intakes for calcium and vitamin D from the institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011; 96: 53-58.
151. Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 2005; 135: 317-322.
152. Fu L, Yun F, Oczak M, Wong BY, Vieth R, Cole DE. Common genetic variants of the vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyvitamin D [25(OH)D] to vitamin D supplementation. Clin Biochem 2009; 42: 1174-1177.
153. Norman AW, Bouillon R. Vitamin D nutritional policy needs a vision for the future. Exp Biol Med (Maywood) 2010; 235: 1034-1045.